GlobeNewswire 10-30 argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 10-29 Lumafield Introduces Auto-Dimensioning, a GD&T Suite for Accurate, NIST-Traceable 3D Measurement
GlobeNewswire 10-28 GD Culture Announces Closing of US$2.8 Million Private Placement
GlobeNewswire 10-28 TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosi...
GlobeNewswire 10-27 Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing M...
GlobeNewswire 10-27 Goliath Drills Multiple High-Grade Gold Intervals Up To 10.72 g/t Au Over 7.83 Meters, Including 20....
Newsfile Corp 10-23 Gathering Strength Towards the "New": The 2025 Global Investment Promotion Conference for the Guangd...
GlobeNewswire 10-22 Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, ...
GlobeNewswire 10-17 Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious c...
GlobeNewswire 10-17 Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation a...
GlobeNewswire 10-17 Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at...
GlobeNewswire 10-16 Fitell Corporation Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire 10-13 Allanite Rare Earths Processing Breakthrough: Successful Completion of Impurity Removal Neutralizati...
GlobeNewswire 10-08 Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoi...
GlobeNewswire 10-03 Fitell Corporation Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Req...
Newsfile Corp 10-02 Canadian-made Stable Isotopes: TMC Group Attends EANM 2025 to Strengthen Global Supply Chains
GlobeNewswire 09-24 New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from...
GlobeNewswire 09-24 Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 202...
GlobeNewswire 09-23 Goliath Completes Over 64,000 Meters Of Drilling in 110 Drill Holes, With 100% Hit Rate In 90 Days O...
GlobeNewswire 09-22 Goliath Intersects Several High-Grade Gold Holes Including 8.45 g/t Au Over 7.13 Meters, Within 5.13...
GlobeNewswire 09-22 Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progre...
GlobeNewswire 09-18 Fitell Corporation Announces Share Consolidation
GlobeNewswire 09-16 Ahold Delhaize USA, Danone North America and The Nature Conservancy Embark on Joint Initiative to Su...
GlobeNewswire 09-10 TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2...
GlobeNewswire 09-08 Goliath Intersects 18.58 g/t Gold Over 5.00 Meters, Drilling Maintains 100% Hit Rate, 90% Of Holes C...